Families with germline SMARCA4 mutations have been reported to develop malignant rhabdoid tumors (SCCHT, AT/RT, renal rhabdoid tumor) and yolk sac tumor (YST), all belonging to the group of embryonal tumors [15,17,18]. This evidence concerns the gene SMARCA4 and yolk sac tumor.